<code id='BE103B9A38'></code><style id='BE103B9A38'></style>
    • <acronym id='BE103B9A38'></acronym>
      <center id='BE103B9A38'><center id='BE103B9A38'><tfoot id='BE103B9A38'></tfoot></center><abbr id='BE103B9A38'><dir id='BE103B9A38'><tfoot id='BE103B9A38'></tfoot><noframes id='BE103B9A38'>

    • <optgroup id='BE103B9A38'><strike id='BE103B9A38'><sup id='BE103B9A38'></sup></strike><code id='BE103B9A38'></code></optgroup>
        1. <b id='BE103B9A38'><label id='BE103B9A38'><select id='BE103B9A38'><dt id='BE103B9A38'><span id='BE103B9A38'></span></dt></select></label></b><u id='BE103B9A38'></u>
          <i id='BE103B9A38'><strike id='BE103B9A38'><tt id='BE103B9A38'><pre id='BE103B9A38'></pre></tt></strike></i>

          Home / comprehensive / explore

          explore


          explore

          author:explore    Page View:59786
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In